Infancy Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Infancy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

Pseudoxanthoma ElasticumEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic Rickets+2 more
Inozyme Pharma16 enrolled7 locationsNCT05734196
Recruiting
Phase 3

ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency

Ectonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy 1
Inozyme Pharma12 enrolled8 locationsNCT07473973
Recruiting
Not Applicable

Mindful Moms, Mindful Meals (MMMM) Study

Nutrition in Early InfancyNutrition HabitsPostpartum Nutrition+1 more
University of New Brunswick72 enrolled1 locationNCT07282964
Recruiting
Phase 2

Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study

Neuroendocrine Cell Hyperplasia of Infancy
Assistance Publique - Hôpitaux de Paris18 enrolled1 locationNCT06471556
Recruiting
Phase 2

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Genetic DiseaseIdiopathic Infantile Hypercalcaemia - Severe FormHypercalcemia, Idiopathic, of Infancy+3 more
Children's Hospital of Philadelphia60 enrolled1 locationNCT03301038
Recruiting

BLUEPRINT: Predicting Long-term Outcomes of Prematurity from Early Life Events

Chronic Lung Disease of InfancyRespiratory DiseasePrematurity
Murdoch Children's Research Institute550 enrolled5 locationsACTRN12624000851561
Recruiting

Iron Absorption and Requirements in Pregnancy and Lactation

PregnancyIron AbsorptionLactation+2 more
University of Oxford250 enrolled1 locationNCT05973552
Recruiting

Controlled oxygen administration in term newborns and young infants requiring mechanical respiratory support and oxygen therapy

Respiratory tract infection of infancyNeonatal hypoxic respiratory failure
Murdoch Childrens Research Institute70 enrolled1 locationACTRN12619000742178